Gene · 710
NIH grants1,786
NIH grants whose papers are about the gene, through NIH's grant-paper links.
441 to 460 of 1,786
Download this page as JSON| Grant | Title | SERPING1 papers | Newest fiscal year |
|---|---|---|---|
| U19AI067798 | Centers for Medical Countermeasures Against Radiation | 1 | 2024 |
| UL1TR001412 | University of Buffalo Clinical and Translational Science Institute | 1 | 2024 |
| UL1TR001425 | Center for Clinical and Translational Science and Training | 1 | 2024 |
| UL1TR001430 | Boston University Clinical and Translational Science Institute | 1 | 2024 |
| UL1TR001442 | UC San Diego Clinical and Translational Research Institute | 1 | 2024 |
| UL1TR001453 | University of Massachusetts Center for Clinical and Translational Science | 1 | 2024 |
| ZIAHG200371 | Genetic Analysis of Complex Inflammatory Disorders | 1 | 2024 |
| ZIAHG200373 | Genetics, Pathophysiology, and Treatment of Dominant Autoinflammatory Diseases | 1 | 2024 |
| R01HL126974 | Fibrinogen and Factor XIII in Venous Thromboembolism | 5 | 2023 |
| R01AR074627 | Bioengineered Skin Sealants | 3 | 2023 |
| R01HL151392 | Safer and more effective FIX therapeutics: impact of codon optimization | 3 | 2023 |
| RM1GM131968 | Resuscitation Strategies for Achieving Thrombo-inflammatory Homeostasis | 3 | 2023 |
| K08HL148510 | C3 Mitigates Epithelial Injury in Pneumonia | 2 | 2023 |
| R01DK077162 | The Biology of NBCe1 in Health and Disease | 2 | 2023 |
| R01GM116961 | Breakthrough Molecular Dynamics Research via an Anton2 Supercomputer | 2 | 2023 |
| R01GM137458 | Engineered probes for sialoglycan detection | 2 | 2023 |
| R01HL149714 | Interactions between the ADORA2b/Sphk1axis and the AE1-Hb switch in red blood cell aging in vivo and in vitro | 2 | 2023 |
| U19AI111825 | Integrating innate and adaptive pathways in vaccine responses | 2 | 2023 |
| F30CA246808 | Investigating the Regulation and Role of FOXM1 in Aggressive Meningioma | 1 | 2023 |
| F31NS117121 | Identifying developmental trajectories characterized in the neuroepithelial stem cell to radial glia transition using single-cell transcriptomics | 1 | 2023 |
Source NIH's project filesgene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/710/grants?page=23